scholarly article | Q13442814 |
P50 | author | Crislyn D'Souza-Schorey | Q87876205 |
P2093 | author name string | Dean Y Li | |
Kirk R Thomas | |||
Lise K Sorensen | |||
Jae Hyuk Yoo | |||
Allie H Grossmann | |||
Zongzhong Tong | |||
Alanna Sedgwick | |||
Sheryl R Tripp | |||
Kenneth F Grossmann | |||
Shannon J Odelberg | |||
Kirill Ostanin | |||
James Clancy | |||
Aaron Rogers | |||
P2860 | cites work | FoxM1 promotes β-catenin nuclear localization and controls Wnt target-gene expression and glioma tumorigenesis | Q24293807 |
Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma | Q24300474 | ||
Slit2-Robo4 signalling promotes vascular stability by blocking Arf6 activity | Q24310601 | ||
Wnt induces LRP6 signalosomes and promotes dishevelled-dependent LRP6 phosphorylation | Q24310980 | ||
Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeability | Q24311667 | ||
A member of the Frizzled protein family mediating axis induction by Wnt-5A | Q24324119 | ||
Essential role of BCL9-2 in the switch between beta-catenin's adhesive and transcriptional functions | Q24561624 | ||
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes | Q24595981 | ||
ARF-GEP(100), a guanine nucleotide-exchange protein for ADP-ribosylation factor 6 | Q24605526 | ||
Microvesicles: mediators of extracellular communication during cancer progression | Q24628728 | ||
Improved survival with vemurafenib in melanoma with BRAF V600E mutation | Q24631953 | ||
The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma | Q24648937 | ||
Interleukin receptor activates a MYD88-ARNO-ARF6 cascade to disrupt vascular stability. | Q39246542 | ||
Wnt5a and Wnt11 interact in a maternal Dkk1-regulated fashion to activate both canonical and non-canonical signaling in Xenopus axis formation | Q39752731 | ||
Wnt11/5a complex formation caused by tyrosine sulfation increases canonical signaling activity | Q39753222 | ||
WNT5A expression increases during melanoma progression and correlates with outcome | Q39939612 | ||
Inhibition of cytohesins by SecinH3 leads to hepatic insulin resistance | Q40196763 | ||
Involvement of Src family kinases in N-cadherin phosphorylation and beta-catenin dissociation during transendothelial migration of melanoma cells. | Q40337286 | ||
Practical spontaneous metastasis model for in vivo therapeutic studies using a human melanoma | Q41149974 | ||
Fluorescent BODIPY-GTP analogs: real-time measurement of nucleotide binding to G proteins | Q43550155 | ||
ADP-ribosylation factors 1 and 6 regulate Wnt/β-catenin signaling via control of LRP6 phosphorylation | Q44679998 | ||
Differential LEF1 and TCF4 expression is involved in melanoma cell phenotype switching | Q45736971 | ||
Blockade of Wnt-5A/frizzled 5 signaling inhibits rheumatoid synoviocyte activation | Q46250097 | ||
Targeting N-cadherin enhances antitumor activity of cytotoxic therapies in melanoma treatment | Q46593339 | ||
Shifts in cadherin profiles between human normal melanocytes and melanomas. | Q47971517 | ||
N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells | Q73812967 | ||
Loss of beta-catenin expression associated with disease progression in malignant melanoma | Q74451230 | ||
Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma | Q81639122 | ||
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma | Q27861062 | ||
Dishevelled 2 recruits beta-arrestin 2 to mediate Wnt5A-stimulated endocytosis of Frizzled 4 | Q28205234 | ||
Maternal wnt11 activates the canonical wnt signaling pathway required for axis formation in Xenopus embryos | Q28242317 | ||
Activated Wnt/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model | Q28306770 | ||
An essential role for ARF6-regulated membrane traffic in adherens junction turnover and epithelial cell migration | Q28348554 | ||
Lentiviral vectors to probe and manipulate the Wnt signaling pathway | Q28472995 | ||
Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context | Q28510950 | ||
Towards an integrated view of Wnt signaling in development | Q29615175 | ||
ARF proteins: roles in membrane traffic and beyond | Q29618078 | ||
Convergence of Wnt, beta-catenin, and cadherin pathways | Q29619504 | ||
High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993 | Q29619885 | ||
ADP-ribosylation factor 6 regulates tumor cell invasion through the activation of the MEK/ERK signaling pathway | Q30448719 | ||
Small-molecule synergist of the Wnt/beta-catenin signaling pathway | Q33282822 | ||
Requirement for Arf6 in breast cancer invasive activities | Q33696335 | ||
Targeting Robo4-dependent Slit signaling to survive the cytokine storm in sepsis and influenza | Q33875118 | ||
Transendothelial migration of melanoma cells involves N-cadherin-mediated adhesion and activation of the beta-catenin signaling pathway | Q33938454 | ||
An accurate, clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma | Q33947068 | ||
β-Catenin signaling increases during melanoma progression and promotes tumor cell survival and chemoresistance | Q33999619 | ||
Wnt5a can both activate and repress Wnt/β-catenin signaling during mouse embryonic development | Q34286592 | ||
GEP100 links epidermal growth factor receptor signalling to Arf6 activation to induce breast cancer invasion. | Q34726188 | ||
SLIT/ROBO1 signaling suppresses mammary branching morphogenesis by limiting basal cell number | Q35086895 | ||
The C-terminal cytoplasmic Lys-thr-X-X-X-Trp motif in frizzled receptors mediates Wnt/beta-catenin signalling | Q35124049 | ||
ARF6-regulated shedding of tumor cell-derived plasma membrane microvesicles | Q35148002 | ||
β-catenin signaling controls metastasis in Braf-activated Pten-deficient melanomas | Q35621787 | ||
E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors | Q35810162 | ||
ARF6-mediated endocytic recycling impacts cell movement, cell division and lipid homeostasis | Q36278707 | ||
The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition. | Q36489436 | ||
Robo4-dependent Slit signaling stabilizes the vasculature during pathologic angiogenesis and cytokine storm | Q36520971 | ||
ADP-ribosylation factor 6 regulates glioma cell invasion through the IQ-domain GTPase-activating protein 1-Rac1-mediated pathway | Q37078757 | ||
ADP-ribosylation factor 6 regulates tumorigenic and invasive properties in vivo | Q37142879 | ||
Interplay of cadherin-mediated cell adhesion and canonical Wnt signaling | Q37698281 | ||
Rethinking the metastatic cascade as a therapeutic target | Q37866635 | ||
Wnt5a: its signalling, functions and implication in diseases | Q37868763 | ||
In melanoma, beta-catenin is a suppressor of invasion. | Q38256043 | ||
Wnt5a control of cell polarity and directional movement by polarized redistribution of adhesion receptors | Q38501378 | ||
Interaction of Wnt and a Frizzled homologue triggers G-protein-linked phosphatidylinositol signalling | Q38529495 | ||
P433 | issue | 265 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | ra14 | |
P577 | publication date | 2013-03-05 | |
P1433 | published in | Science Signaling | Q7433604 |
P1476 | title | The small GTPase ARF6 stimulates β-catenin transcriptional activity during WNT5A-mediated melanoma invasion and metastasis | |
P478 | volume | 6 |
Q38757495 | A Nexus Consisting of Beta-Catenin and Stat3 Attenuates BRAF Inhibitor Efficacy and Mediates Acquired Resistance to Vemurafenib |
Q90721786 | A Targeted Quantitative Proteomic Approach Assesses the Reprogramming of Small GTPases during Melanoma Metastasis |
Q38093429 | A Wnt-er migration: the confusing role of β-catenin in melanoma metastasis. |
Q34341405 | A river runs through it: how autophagy, senescence, and phagocytosis could be linked to phospholipase D by Wnt signaling |
Q28115305 | ARF6 Is an Actionable Node that Orchestrates Oncogenic GNAQ Signaling in Uveal Melanoma |
Q34917691 | ARF6 inhibition stabilizes the vasculature and enhances survival during endotoxic shock |
Q37036357 | ARF6-regulated endocytosis of growth factor receptors links cadherin-based adhesion to canonical Wnt signaling in epithelia |
Q89823735 | Aberrant WNT/CTNNB1 Signaling as a Therapeutic Target in Human Breast Cancer: Weighing the Evidence |
Q89108028 | Aberrant endocytosis leads to the loss of normal mitotic spindle orientation during epithelial glandular morphogenesis |
Q93001320 | An ARF6-Exportin-5 axis delivers pre-miRNA cargo to tumour microvesicles |
Q90573431 | Arf6 regulates RhoB subcellular localization to control cancer cell invasion |
Q34516773 | Attacking the supply wagons to starve cancer cells to death |
Q36432043 | BMI1 induces an invasive signature in melanoma that promotes metastasis and chemoresistance |
Q33769672 | Challenging role of Wnt5a and its signaling pathway in cancer metastasis (Review). |
Q51742717 | Contact-dependent transfer of TiO₂ nanoparticles between mammalian cells. |
Q38238576 | Developmental pathways activated in melanocytes and melanoma |
Q64121542 | Down-regulation of FZD3 receptor suppresses growth and metastasis of human melanoma independently of canonical WNT signaling |
Q38786887 | Dual mechanisms of action of the RNA-binding protein human antigen R explains its regulatory effect on melanoma cell migration. |
Q30384677 | EGF-reduced Wnt5a transcription induces epithelial-mesenchymal transition via Arf6-ERK signaling in gastric cancer cells. |
Q36539110 | Endothelial Robo4 suppresses breast cancer growth and metastasis through regulation of tumor angiogenesis |
Q36957310 | Enhancement of β-catenin activity by BIG1 plus BIG2 via Arf activation and cAMP signals |
Q46380429 | Haemorrhagic snake venom metalloproteases and human ADAMs cleave LRP5/6, which disrupts cell-cell adhesions in vitro and induces haemorrhage in vivo. |
Q37570262 | Hypoxia induces phenotypic plasticity and therapy resistance in melanoma via the tyrosine kinase receptors ROR1 and ROR2. |
Q27680018 | Integrated Conformational and Lipid-Sensing Regulation of Endosomal ArfGEF BRAG2 |
Q38385463 | Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significance |
Q38982133 | Interleukin-6 drives melanoma cell motility through p38α-MAPK-dependent up-regulation of WNT5A expression |
Q38111220 | Melanoma metastasis: new concepts and evolving paradigms |
Q48324206 | MiR 376c inhibits osteoblastogenesis by targeting Wnt3 and ARF-GEF-1 -facilitated augmentation of beta-catenin transactivation |
Q35573020 | Molecular Role of RNF43 in Canonical and Noncanonical Wnt Signaling |
Q46396184 | Molecular genetic analysis of the melanoma regulatory locus in Xiphophorus interspecies hybrids. |
Q56428911 | Molecular pathology of cutaneous melanoma |
Q53103604 | Multiparameter analysis of naevi and primary melanomas identifies a subset of naevi with elevated markers of transformation. |
Q97421855 | Mutation profile of primary subungual melanomas in Caucasians |
Q42088910 | Pathological functions of the small GTPase Arf6 in cancer progression: Tumor angiogenesis and metastasis |
Q26865736 | Pathways and therapeutic targets in melanoma |
Q36177152 | Pdlim7 Regulates Arf6-Dependent Actin Dynamics and Is Required for Platelet-Mediated Thrombosis in Mice |
Q47700196 | Progesterone and calcitriol reduce invasive potential of endometrial cancer cells by targeting ARF6, NEDD9 and MT1-MMP. |
Q34699735 | SLIT/ROBO2 signaling promotes mammary stem cell senescence by inhibiting Wnt signaling. |
Q48623673 | Small GTPase ARF6 controls VEGFR2 trafficking and signaling in diabetic retinopathy. |
Q64986290 | Sphingolipids inhibit endosomal recycling of nutrient transporters by inactivating ARF6. |
Q36167110 | Structure-activity relationship studies of QS11, a small molecule Wnt synergistic agonist. |
Q38573776 | Targeting the WNT Signaling Pathway in Cancer Therapeutics |
Q90835926 | Temporal activation of WNT/β-catenin signaling is sufficient to inhibit SOX10 expression and block melanoma growth |
Q30275740 | The BRAG/IQSec family of Arf GEFs |
Q95277349 | The Role of ARF Family Proteins and Their Regulators and Effectors in Cancer Progression: A Therapeutic Perspective |
Q91796640 | The Small GTPase Arf6: An Overview of Its Mechanisms of Action and of Its Role in Host⁻Pathogen Interactions and Innate Immunity |
Q38867422 | The WNT-less wonder: WNT-independent β-catenin signaling |
Q38627456 | The Wnts of change: How Wnts regulate phenotype switching in melanoma |
Q37742632 | The biology of uveal melanoma |
Q26852972 | The role of Ryk and Ror receptor tyrosine kinases in Wnt signal transduction |
Q38851918 | The role of thioredoxin reductase 1 in melanoma metabolism and metastasis |
Q51245130 | The small GTPase ARF6 regulates protein trafficking to control cellular function during development and in disease. |
Q51141252 | The small GTPase Arf6 regulates sea urchin morphogenesis. |
Q26782222 | Therapy for BRAFi-Resistant Melanomas: Is WNT5A the Answer? |
Q92005592 | Tris DBA palladium is an orally available inhibitor of GNAQ mutant uveal melanoma in vivo |
Q91211987 | Tspan8-β-catenin positive feedback loop promotes melanoma invasion |
Q26777942 | WNT-5A: signaling and functions in health and disease |
Q51674853 | WNT5A and Its Receptors in the Bone-Cancer Dialogue. |
Q38628775 | WNT5A-mediated β-catenin-independent signalling is a novel regulator of cancer cell metabolism |
Q38150869 | Why is melanoma so metastatic? |
Q64981255 | Wnt Signaling Upregulates Teneurin-3 Expression via Canonical and Non-canonical Wnt Pathway Crosstalk. |
Q28077330 | Wnt Signaling in Cell Motility and Invasion: Drawing Parallels between Development and Cancer |
Q51518956 | Wnt signaling in cancer. |
Q49900550 | Wnt-signaling enhances neural crest migration of melanoma cells and induces an invasive phenotype. |
Q26738408 | Wnt5a Signaling in Cancer |
Q38795141 | Wnt5a inhibited human trophoblast cell line HTR8/SVneo invasion: implications for early placentation and preeclampsia |
Q35108871 | lincRNA-RoR and miR-145 regulate invasion in triple-negative breast cancer via targeting ARF6. |
Search more.